Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
When it comes to Treatment Details for vulvar cancer, patients need clear, evidence‑based information to make informed decisions. Liv Hospital’s multidisciplinary team combines international expertise with state‑of‑the‑art technology to deliver personalized care for every stage of the disease. Each year, thousands of women worldwide seek specialized oncologic services, and vulvar cancer accounts for roughly 5% of all gynecologic malignancies—a reminder of the importance of early detection and tailored therapy. This page walks you through every aspect of the treatment pathway, from initial assessment to long‑term survivorship, ensuring you understand the options, expected outcomes, and supportive resources available at our JCI‑accredited facility.
Our approach integrates surgical precision, advanced radiation techniques, and systemic therapies, all coordinated by a dedicated international patient services team. Whether you are exploring curative intent or palliative measures, the following sections provide the detailed guidance you need to navigate your journey with confidence.
Vulvar cancer treatment is highly individualized, reflecting tumor size, location, depth of invasion, and lymph node involvement. The primary modalities include surgery, radiation therapy, chemotherapy, targeted agents, and emerging immunotherapies. In many cases, a combination of these approaches yields the best oncologic control while preserving function and quality of life.
At Liv Hospital, a tumor board comprising gynecologic oncologists, radiation oncologists, medical oncologists, pathologists, and radiologists reviews each case. This collaborative review ensures that the chosen plan aligns with the latest clinical guidelines and the patient’s personal preferences.
Understanding these variables helps patients anticipate the Treatment Details that will be most effective for their unique situation.
Surgery remains the cornerstone for localized vulvar cancer, aiming to remove the tumor with clear margins while preserving as much healthy tissue as possible. The type of procedure is dictated by tumor size, depth, and involvement of adjacent structures.
When feasible, laparoscopic or robotic‑assisted techniques reduce postoperative pain and shorten hospital stays. Liv Hospital’s robotic platform offers three‑dimensional visualization, enhancing precision during complex resections.
Our surgeons discuss these risks in detail, ensuring that patients have realistic expectations and a clear understanding of the Treatment Details surrounding operative care.
Radiation therapy is employed either as a definitive treatment for patients who are not surgical candidates or as an adjuvant modality to reduce recurrence risk after surgery. Modern techniques allow precise dose delivery while sparing surrounding healthy tissue.
For select cases, interstitial or surface brachytherapy delivers high‑dose radiation directly to the tumor bed, shortening treatment duration and reducing skin toxicity.
Our radiation oncologists tailor dose schedules—typically 45–66 Gy in 1.8–2 Gy fractions—based on tumor characteristics, ensuring optimal balance between efficacy and tolerability. Detailed Treatment Details are discussed during the planning phase.
Systemic therapy addresses microscopic disease, improves surgical outcomes, and offers options for metastatic or recurrent vulvar cancer. The choice of agents depends on tumor biology, prior treatments, and patient health status.
For tumors expressing epidermal growth factor receptor (EGFR) or harboring specific mutations, agents such as cetuximab or pembrolizumab (when PD‑L1 is positive) have shown clinical benefit. Molecular profiling is performed routinely at Liv Hospital to identify eligible patients.
Checkpoint inhibitors are emerging as promising options, particularly in HPV‑associated vulvar cancers. Clinical trials at our institution evaluate novel agents, offering patients access to cutting‑edge treatment.
Our oncology pharmacists and nursing team provide comprehensive education on side‑effect mitigation, ensuring patients feel confident throughout the course of systemic treatment. Detailed Treatment Details are documented in personalized care plans.
Successful cancer care extends beyond the active treatment phase. Structured follow‑up detects recurrences early, while rehabilitation services address functional and psychosocial needs.
Our multidisciplinary rehab team offers:
Patients are educated on self‑examination, lifestyle modifications (smoking cessation, balanced diet), and vaccination against HPV to reduce the risk of secondary lesions.
By integrating survivorship planning into the overall care pathway, Liv Hospital ensures that every patient receives comprehensive Treatment Details that encompass both oncologic control and quality‑of‑life considerations.
Liv Hospital combines JCI accreditation, a multilingual care team, and cutting‑edge technology to deliver world‑class vulvar cancer treatment to international patients. Our 360‑degree patient services include visa assistance, airport transfers, interpreter support, and comfortable accommodation options, allowing you to focus solely on recovery. With a proven track record in complex oncologic surgeries and personalized systemic therapies, we provide the expertise and compassionate care you deserve.
Ready to discuss your personalized treatment plan? Contact our International Patient Services team today to schedule a confidential consultation and begin your journey toward recovery with Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
Vulvar cancer treatment is individualized based on tumor size, depth, lymph‑node involvement, and patient health. Surgery aims to remove the tumor with clear margins, while radiation can be used as definitive therapy or adjuvant to reduce recurrence. Systemic options such as chemotherapy, targeted agents (e.g., cetuximab) and immunotherapy (checkpoint inhibitors) address microscopic disease and metastatic cases. Often a multimodal approach yields the best oncologic control while preserving function.
At Liv Hospital, gynecologic oncologists, radiation oncologists, medical oncologists, pathologists and radiologists convene in a tumor board. They evaluate stage, tumor genetics, patient age, comorbidities, and personal preferences. The board aligns the plan with the latest clinical guidelines, ensuring that surgery, radiation, or systemic therapy—or a combination—is chosen to maximize efficacy and quality of life.
For small, well‑defined lesions, wide local excision (WLE) with 1‑2 cm margins is preferred. Larger or deeper tumors may require radical local excision (RLE) or partial/total vulvectomy. Lymphadenectomy assesses nodal spread. Minimally invasive approaches, such as laparoscopic or robotic‑assisted surgery, are used when feasible to reduce pain and hospital stay, with Liv Hospital offering a 3‑D robotic platform for precise resections.
Post‑treatment care includes a surveillance schedule: every 3–4 months for the first two years, every 6 months for years 3–5, then annually. Rehabilitation services offer pelvic floor physiotherapy, occupational therapy, and counseling. Patients receive education on self‑examination, lifestyle changes, and HPV vaccination to lower recurrence risk. International patients also benefit from visa assistance, interpreter services, and comfortable accommodation.
Liv Hospital is JCI‑accredited, ensuring adherence to international quality standards. A multilingual team provides interpreter support, while state‑of‑the‑art surgical robots and advanced radiation platforms enable precise treatment. The International Patient Services department assists with visas, airport transfers, and lodging, allowing patients to focus on recovery. Proven outcomes in complex oncologic surgeries and personalized systemic therapies further differentiate Liv Hospital.
BlogCancerNov 03, 2025Vaginal cancer is a rare cancer that’s hard to spot early. About 70% of vaginal cancer cases are foun...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
